Biopharma needs a new R&D, innovation model
Strategic partnerships are one way for biopharmaceutical companies to expand capabilities and offerings and proactively define their future versus having it defined for them.
Ruchin Kansal
Ruchin Kansal, leader of the Digital Business Strategy Group’s healthcare team at Virtusa and author of “Redefining Innovation: Embracing the 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry.”